BIZENGRI vs IMDELLTRA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. BIZENGRI and IMDELLTRA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BIZENGRI	IMDELLTRA
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ZENOCUTUZUMAB-ZBCO	TARLATAMAB-DLLE
Manufacturer	Merus N.V.	Amgen Inc
Dosage forms	Injectable	Kit
Drug class	—	—
Boxed warning	Boxed warning	Boxed warning
Treats	Lung Neoplasms, Small Cell Lung Carcinoma	Lung Neoplasms

bizengri imdelltra

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

ZENOCUTUZUMAB-ZBCO

TARLATAMAB-DLLE

Manufacturer

Merus N.V.

Amgen Inc

Dosage forms

Injectable

Kit

Drug class

—

Boxed warning

Treats

Lung Neoplasms, Small Cell Lung Carcinoma

Lung Neoplasms

Frequently asked questions

What is the difference between Bizengri and Imdelltra?

Bizengri contains Zenocutuzumab-Zbco, while Imdelltra contains Tarlatamab-Dlle — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.